ATE365544T1 - Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon - Google Patents
Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davonInfo
- Publication number
- ATE365544T1 ATE365544T1 AT02722540T AT02722540T ATE365544T1 AT E365544 T1 ATE365544 T1 AT E365544T1 AT 02722540 T AT02722540 T AT 02722540T AT 02722540 T AT02722540 T AT 02722540T AT E365544 T1 ATE365544 T1 AT E365544T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- deconstanting
- anthistaminic
- production
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000890 drug combination Substances 0.000 title 1
- 239000000850 decongestant Substances 0.000 abstract 3
- RRJFVPUCXDGFJB-UHFFFAOYSA-N Fexofenadine hydrochloride Chemical compound Cl.C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RRJFVPUCXDGFJB-UHFFFAOYSA-N 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 229960003592 fexofenadine Drugs 0.000 abstract 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 abstract 1
- 229960000354 fexofenadine hydrochloride Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007916 tablet composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2002/001068 WO2003084510A1 (en) | 2002-04-04 | 2002-04-04 | Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE365544T1 true ATE365544T1 (de) | 2007-07-15 |
Family
ID=28686908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02722540T ATE365544T1 (de) | 2002-04-04 | 2002-04-04 | Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8263124B2 (de) |
| EP (1) | EP1490034B1 (de) |
| AT (1) | ATE365544T1 (de) |
| AU (1) | AU2002253425B2 (de) |
| CA (1) | CA2481377A1 (de) |
| DE (1) | DE60220953T2 (de) |
| WO (1) | WO2003084510A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20033019A3 (cs) * | 2001-04-09 | 2004-07-14 | Teva Pharmaceutical Industries Ltd. | Polymorfní formy chloridu fexofenadinu |
| EP1474392A1 (de) | 2002-06-10 | 2004-11-10 | Teva Pharmaceutical Industries Ltd. | Polymorphe form xvi von fexofenadin-hydrochlorid |
| KR20060076319A (ko) * | 2003-09-24 | 2006-07-04 | 콤비네이토릭스, 인코포레이티드 | 약물 조합들을 투여하는 치료 요법 |
| US20080085311A1 (en) * | 2006-10-05 | 2008-04-10 | Tripathi Sanjay S | Antihistamine-decongestant combinations |
| WO2008114280A1 (en) * | 2007-03-21 | 2008-09-25 | Lupin Limited | Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3878217A (en) * | 1972-01-28 | 1975-04-15 | Richardson Merrell Inc | Alpha-aryl-4-substituted piperidinoalkanol derivatives |
| US4996061A (en) * | 1987-10-07 | 1991-02-26 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutical composition for piperidinoalkanol-decongestant combination |
| NZ501248A (en) * | 1997-08-26 | 2001-06-29 | Aventis Pharma Inc | Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
| PT1035834E (pt) * | 1997-12-05 | 2002-09-30 | Alza Corp | Forma de dosagem osmotica que compreende primeiro e segundo revestimentos |
| US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
| AU2001261165A1 (en) * | 2000-05-05 | 2001-11-20 | Aventis Pharmaceuticals Inc. | Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride |
| US6613906B1 (en) * | 2000-06-06 | 2003-09-02 | Geneva Pharmaceuticals, Inc. | Crystal modification |
| CZ20033019A3 (cs) * | 2001-04-09 | 2004-07-14 | Teva Pharmaceutical Industries Ltd. | Polymorfní formy chloridu fexofenadinu |
| US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
| KR20070007196A (ko) * | 2004-04-26 | 2007-01-12 | 테바 파마슈티컬 인더스트리즈 리미티드 | 펙소페나딘 히드로클로라이드의 결정형 및 이의 제조 방법 |
-
2002
- 2002-04-04 DE DE60220953T patent/DE60220953T2/de not_active Expired - Fee Related
- 2002-04-04 AU AU2002253425A patent/AU2002253425B2/en not_active Ceased
- 2002-04-04 WO PCT/IB2002/001068 patent/WO2003084510A1/en not_active Ceased
- 2002-04-04 US US10/510,064 patent/US8263124B2/en not_active Expired - Fee Related
- 2002-04-04 AT AT02722540T patent/ATE365544T1/de not_active IP Right Cessation
- 2002-04-04 EP EP02722540A patent/EP1490034B1/de not_active Expired - Lifetime
- 2002-04-04 CA CA002481377A patent/CA2481377A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1490034B1 (de) | 2007-06-27 |
| DE60220953D1 (de) | 2007-08-09 |
| AU2002253425A1 (en) | 2003-10-20 |
| CA2481377A1 (en) | 2003-10-16 |
| AU2002253425B2 (en) | 2008-09-25 |
| US20060182800A1 (en) | 2006-08-17 |
| US8263124B2 (en) | 2012-09-11 |
| DE60220953T2 (de) | 2008-02-28 |
| EP1490034A1 (de) | 2004-12-29 |
| WO2003084510A1 (en) | 2003-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1115484T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson | |
| DE602005007339D1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
| ATE397933T1 (de) | Kristallinform gamma-d von ivabradine- hydrochlorid, verfahren zu dessen herstellung und diesen enthaltende pharmazeutische zusammensetzung | |
| HUP0303876A3 (en) | Preparation of pharmaceutical compositions for treatment of type 2 diabetes using piperidine or tiazolidine, inhibitors of dipeptidyl peptidase iv | |
| ATE454138T1 (de) | Tablette mit modifizierter freisetzung von bupropion hydrochlorid | |
| DK1675591T3 (da) | Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer | |
| ATE397449T1 (de) | Kristallinform beta-d von ivabradine-hydrochlorid,verfahren zu dessen herstellung und diesen enthaltende pharmazeutische zusammensetzung | |
| NO20080827L (no) | Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon | |
| BRPI0413393A (pt) | fexofenadina, composição farmaceuticamente aceitável, método de tratamento antihistamìnico, composição, processo para preparar fexofenadina e uso de fexofenadina | |
| DE60317803D1 (de) | Pharmazeutische zusammensetzungen enthaltend cyclosporin zur oralen verabreichung | |
| HUP0200438A3 (en) | Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
| ATE367152T1 (de) | Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung | |
| NO20053119D0 (no) | Farmasoytiske sarmmensetninger med fentanyl for intranasal administrasjon. | |
| DE60304599D1 (de) | Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| EA200401515A1 (ru) | Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а | |
| ATE358477T1 (de) | Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat | |
| DE602004024417D1 (de) | Neues verfahren zur herstellung von pleuromutilinderivaten | |
| DE60318167D1 (de) | Arzneiform und Verfahren zu ihrer Herstellung | |
| DE602005011326D1 (de) | Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid | |
| IL164903A0 (en) | Processes for preparation of polymorphic form II of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof | |
| UA88481C2 (ru) | Донепезила фумарат, пригодный для получения фармацевтических композиций | |
| TW200606164A (en) | New compounds | |
| HUP0301082A2 (hu) | Új polimorf olanzapine hidroklorid sók, eljárás ezek előállítására, az ezeket tartalmazó gyógyászati készítmények és felhasználásuk | |
| ATE374172T1 (de) | Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon | |
| DE60220953D1 (de) | Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |